AFM and psoriasis: Consistent with the role of αLβ2 in the immunological synapse (reviewed by Walling and Kim [110]), efalizumab decouples the internalization of engaged TCR/CD3 complexes, possibly explaining the hyporesponsive state of T cells that occurs in efalizumab-treated psoriasis patients [111].